Neurocine Biosciences won FDA approval on Tuesday for a new formulation that may help Ingrezza go down in a more delightful ...
GSK’s vaccines portfolio is front and center as it kicks off 2024. The UK pharma made £7.36 billion ($9.18 billion) in ...
Pfizer trimmed a handful of programs from its pipeline Wednesday morning as part of its first-quarter earnings update ...
Real Chemistry plans to harness the “Wild West” of GLP-1 social media and reams of competitive data in the drug category with ...
Novartis is looking to build on its radiopharma research machinery. The maker of Lutathera and Pluvicto has expanded its ...
(This story is from our new Health Tech newsletter. If you’d like to sign up, just click here.) Piction Health, which ...
UnitedHealth Group's CEO Andrew Witty is set to testify before lawmakers on Wednesday to explain how the company handled ...
Moderna is inviting LinkedIn and Instagram scrollers to take a break with its scientists in a Coffee Break Science series that started this week. The short videos lead off with infectious disease ...
Antitrust regulators at the Federal Trade Commission expanded their campaign on what they call “junk” patents, sending a new round of warning letters to drug companies about their ...